The impact of Bituvi/Bikonprenol tablets on renal function and the possibility of recovery

Biktarvy is a commonly used HIV [ AIDS ( AIDS)] combination antiviral drug. The active release of the TAF component (tenofovir alafenamide) in the body is lower than that of traditional TDF (tenofovir disoproxil disoproxil), thus theoretically reducing the risk of nephrotoxicity. Clinical studies have shown that the use of Bicronol tablets has a relatively small impact on renal function, and most healthy individuals and HIV patients can maintain stable renal function during treatment.

Research shows thatHIV patients usually have slight improvements in their serum creatinine levels and glomerular filtration rate (eGFR) after switching from TDF to TAF regimen, indicating that TAF causes less damage to the kidneys. For healthy people, the changes in renal function are generally not obvious when short-term use of Bikeren Prenol Tablets as PEP or clinical short-term intervention. However, Bikeren may still have some effects on people with existing kidney function problems, so a full kidney function assessment should be performed before starting treatment.

If abnormal renal function indicators occur during use, such as increased blood creatinine or increased urinary protein, the drug should be discontinued immediately and consult a doctor. Clinical practice shows that some patients' renal function can gradually recover after stopping medication, but the degree of recovery is closely related to the individual's basic condition, comorbid diseases, and the duration of medication. Therefore, for patients with chronic kidney disease or elderly patients, Bikern Prenol tablets need to be used with caution, and it is recommended to regularly monitor blood and urine indicators to detect potential problems in time.

Generally speaking, Bicronol tablets have less impact on renal function, but individual differences still need to be paid attention to. Regular monitoring of kidney function, maintaining proper hydration, and avoiding concomitant use of medications that may burden the kidneys are keys to safe use. This feature of Bikeren Prenol Tablets makes it more advantageous in HIV treatment and PEP applications, providing patients with a safe and effective treatment option.

Reference materials:https://www.biktarvy.com/